Bradley J. Monk

Florida Cancer Specialists & Research Institute

Also affiliated with Science History Institute, The US Oncology Network

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 22 papers. Top paper: “MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum”.

MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

Journal of Clinical Oncology(2020)10.1200/jco.20.01164

N/A

4.6DataRank · unranked

153 citations

Rachel N. Grisham, Susana Banerjee, Elsa Kalbacher, Mansoor Raza Mirza, Ignacio Romero +25 more

Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.04.012

N/A

1.3DataRank · unranked

36 citations

José Alejandro Pérez Fidalgo, Bradley J. Monk, Ignacio Tusquets, Colleen McCormick, José Fuentes +20 more

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0621

N/A

0.949DataRank · unranked

22 citations

Ignace Vergote, Susana Banerjee, Esther Drill, Elsa Kalbacher, Mansoor Raza Mirza +25 more

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

New England Journal of Medicine(2016)10.1056/nejmoa1505067

N/A

0.886DataRank · unranked

367 citations

Mark F. Brady, Richard T. Penson, Helen Huang, Michael J. Birrer, Joan L. Walker +10 more

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005919

N/A

0.812DataRank · unranked

25 citations

Bradley J. Monk, Els Van Nieuwenhuysen, Kathleen N. Moore, Michel Fabbro, David M. O’Malley +16 more

Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

Journal of Clinical Oncology(2025)10.1200/jco-25-00112

N/A

0.722DataRank · unranked

36 citations

Els Van Nieuwenhuysen, Carol Aghajanian, Véronique D’Hondt, Bradley J. Monk, Andrew R. Clamp +20 more

Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279

Journal of Clinical Oncology(2024)10.1200/jco.23.02235

N/A

0.637DataRank · unranked

19 citations

Wei Deng, I. Peterson, Robert S. Mannel, J. S. Thompson, Elizabeth Lokich +12 more

Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008

Annals of Oncology(2025)10.1016/j.annonc.2025.09.003

N/A

0.491DataRank · unranked

14 citations

Wei Deng, Kevin Albuquerque, W-J Koh, Jyoti Mayadev, A. Heugel +15 more

Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.009

N/A

0.473DataRank · unranked

7 citations

Bhavana Pothuri, Ana Oaknin, Whitney S. Graybill, Ana Beatriz Sánchez, Colleen McCormick +15 more

ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101760

N/A

0.449DataRank · unranked

9 citations

Kristin Bixel, Dana M. Chase, Allison Quick, Colleen McCormick, Destin Black +10 more

Data from Stress, Immunity, and Cervical Cancer: Biobehavioral Outcomes of a Randomized Clinical Trail

(2023)10.1158/1078-0432.c.6518412.v1

N/A

0DataRank · unranked

0 citations

Lari Wenzel, Kathryn Osann, Aysun Doğan, Nissa Chantana, Astrid Reina-Patton +6 more

Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations

European Journal of Cancer(2024)10.1016/j.ejca.2024.114024

N/A

0DataRank · unranked

26 citations

Markus Joerger, Yung‐Jue Bang, Ron H.J. Mathijssen, Caicun Zhou, Li Zhang +6 more

Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.005

N/A

0DataRank · unranked

13 citations

Helen Huang, Bradley J. Monk, Yong-Beom Kim, Moon‐Hong Kim, Paul DiSilvestro +17 more

Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.02.023

N/A

0DataRank · unranked

10 citations

Helen Huang, Bradley J. Monk, Yong-Beom Kim, Moon-Hong Kim, Ashley Stuckey +14 more

Repurposing Food and Drug Administration-approved cancer therapies: exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101938

N/A

0DataRank · unranked

3 citations

Rachel N. Grisham, Robert L. Coleman, Lauren Cobb, Bradley J. Monk, Thomas J. Herzog +3 more

Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.012

N/A

0DataRank · unranked

22 citations

Sherry Shen, Bradley J. Monk, David S.P. Tan, Angélica Nogueira‐Rodrigues, Daisuke Aoki +3 more

Longitudinal Changes in Sleep: Associations with Shifts in Circulating Cytokines and Emotional Distress in a Cancer Survivor Population

International Journal of Behavioral Medicine(2021)10.1007/s12529-020-09950-0

N/A

0DataRank · unranked

15 citations

Kathryn Osann, Susie Hsieh, Aditi Wahi, Bradley J. Monk, Lari Wenzel +2 more

The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.028

N/A

0DataRank · unranked

14 citations

Chunqiao Tian, Joshua P. Kesterson, Michael Richardson, Ken Lin, Krishnansu S. Tewari +14 more

Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.10.017

N/A

0DataRank · unranked

26 citations

Leslie M. Randall, Fumiko Chino, Bradley J. Monk, John Farley, Roisin E. O’Cearbhaill +1 more

Endometrial carcinosarcoma

International Journal of Gynecological Cancer(2022)10.1136/ijgc-2022-004073

N/A

0DataRank · unranked

95 citations

Isabelle Ray‐Coquard, Nicole Concin, Natalie Y.L. Ngoi, Philippe Morice, Giuseppe Caruso +35 more

#267 Quality-adjusted time without symptoms of disease or toxicity in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel in the ENGOT-EN6/GOG-3031/RUBY trial

International Journal of Gynecological Cancer(2023)10.1136/ijgc-2023-esgo.13

N/A

0DataRank · unranked

2 citations

Line Bjørge, Robert L. Coleman, Oleksandr Zub, Eirwen M. Miller, Roberto Angioli +15 more

Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5502

N/A

0DataRank · unranked

13 citations

Wei Deng, Loren K. Mell, Debra L. Richardson, Joan L. Walker, Laura L. Holman +15 more